-
1
How to use monoclonal antibody-based therapy in ALL
Published 2025-06-01Subjects: Get full text
Article -
2
Immunobridging Trials: An Important Tool to Protect Vulnerable and Immunocompromised Patients Against Evolving Pathogens
Published 2024-12-01Subjects: Get full text
Article -
3
-
4
The potential role of nanobodies in asthma therapy
Published 2025-01-01Subjects: Get full text
Article -
5
Development of monoclonal antibodies against P. gingivalis Mfa1 and their protective capacity in an experimental periodontitis model
Published 2025-01-01Subjects: Get full text
Article -
6
Improving predictability of IgE-high type 2 chronic sinusitis with nasal polyps in the biologic era
Published 2022-05-01Subjects: Get full text
Article -
7
-
8
Navigating Recent Changes in Dosing Information: Dynamics of FDA‐Approved Monoclonal Antibodies in Post‐Marketing Realities
Published 2025-01-01Subjects: Get full text
Article -
9
New specific migraine prevention: monoclonal antibodies against calcitonin gene-related peptide and its receptor
Published 2019-12-01Subjects: Get full text
Article -
10
Lipid nanoparticles deliver DNA-encoded biologics and induce potent protective immunity
Published 2025-01-01Subjects: Get full text
Article -
11
Case report: Single infusion of combined anti-CD20 and anti-CD38 monoclonal antibodies in pediatric refractory lupus nephritis
Published 2025-01-01Subjects: Get full text
Article -
12
Revolutionizing acute myeloid leukemia treatment: a systematic review of immune-based therapies
Published 2025-01-01Subjects: Get full text
Article -
13
Editorial: The immune response to therapeutic antibodies
Published 2025-02-01Subjects: Get full text
Article -
14
Erenumab effectiveness and safety: comparison of real-life data and clinical trial results
Published 2021-12-01Subjects: Get full text
Article -
15
Improving the N-glycosylation occupancy of plant-produced IgG1 by engineering the amino acid environment at Asn297
Published 2025-01-01Subjects: “…monoclonal antibodies…”
Get full text
Article -
16
-
17
The Role of the New Anti-CD20 Monoclonal Antibodies in Active Relapsing – Remitting Multiple Sclerosis Treatment: Efficacy and Safety of ofatumumab
Published 2024-03-01Subjects: Get full text
Article -
18
Problems of creating antibody phage libraries and their solutions
Published 2024-04-01Subjects: Get full text
Article -
19
Drugs as a cause of perforating dermatoses – a literature review
Published 2024-11-01Subjects: Get full text
Article -
20
Current and Novel Therapies for Cluster Headache: A Narrative Review
Published 2024-11-01Subjects: “…Calcitonin gene-related peptide monoclonal antibodies…”
Get full text
Article